Dr. Kopp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3710 SW US Veterans Hospital Rd
Portland, OR 97239Phone+1 702-341-3164- Is this information wrong?
Summary
- Dr. Ryan Kopp is an urologist in Portland, OR and is affiliated with VA Portland Healthcare System. He received his medical degree from Indiana University School of Medicine, residency training at UC San Diego, and completed his urologic oncology fellowship at Memorial Sloan Kettering Cancer Center. He has held an appointment at Oregon Health & Science University and the VA Portland Healthcare System since 2015. He specializes in urologic oncology and is experienced in multidisciplinary care of genitourinary cancers (prostate, kidney, testicular, bladder), genetic research, cancer early detection, and clinical trials.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2013 - 2015
- University of California (San Diego) Medical CenterResidency, Urology, 2009 - 2013
- University of California (San Diego) Medical CenterResidency, Surgery, 2007 - 2009
- Indiana University School of MedicineClass of 2007
Certifications & Licensure
- OR State Medical License 2015 - 2025
- NY State Medical License 2012 - 2016
- CA State Medical License 2009 - 2013
- American Board of Urology Urology
Clinical Trials
- A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss Start of enrollment: 2024 May 31
- S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer Start of enrollment: 2017 Feb 24
- Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants Start of enrollment: 2016 Jun 13
- Join now to see all
Publications & Presentations
PubMed
- 104 citationsSurvival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score.Ryan Kopp, Reza Mehrazin, Kerrin Palazzi, Michael A. Liss, Ramzi Jabaji
BJU International. 2014-11-01 - 71 citationsFeasibility and efficacy of neoadjuvant sunitinib before nephron‐sparing surgeryJonathan L. Silberstein, Frederick Millard, Reza Mehrazin, Ryan Kopp, Wassim M. Bazzi
BJU International. 2010-11-01 - 27 citationsIdentification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals...Jonine D. Figueroa, Candace D. Middlebrooks, A. Rouf Banday, Yuanqing Ye, Montserrat Garcia-Closas
Human Molecular Genetics. 2016-03-15
Grant Support
- Integration of Magnetic Resonance Imaging and Protein Biomarkers for Identification of Aggressive Prostate CancerCDMRP Prostate Cancer Research ProgramPresent
Hospital Affiliations
- Portland HCSPortland, Oregon
- OHSU HospitalPortland, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: